chronic obstructive pulmonary disease

Tse, G., Emmanuel, B., Ariti, C., Bafadhel, M., Papi, A., Carter, V., et al. (2023). A Long-Term Study of Adverse Outcomes Associated With Oral Corticosteroid Use in COPD. Int J Chron Obstruct Pulmon Dis, 18, 2565-2580. http://doi.org/10.2147/copd.s433326
Graul, E. L., Nordon, C., Rhodes, K., Marshall, J., Menon, S., Kallis, C., et al. (2023). Temporal Risk of Non-Fatal Cardiovascular Events Post COPD Exacerbation: A Population-based Study. Am J Respir Crit Care Med. http://doi.org/10.1164/rccm.202307-1122OC
Ismaila, A. S., Rothnie, K. J., Wood, R. P., Banks, V. L., Camidge, L. J., Czira, A., et al. (2023). Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study. Respir Res, 24, 229. http://doi.org/10.1186/s12931-023-02523-1
Stone, P. W., Osen, M., Ellis, A., Coaker, R., & Quint, J. K. (2023). Prevalence of Chronic Obstructive Pulmonary Disease in England from 2000 to 2019. Int J Chron Obstruct Pulmon Dis, 18, 1565-1574. http://doi.org/10.2147/copd.s411739
Raslan, A. S., Quint, J. K., & Cook, S. (2023). All-Cause, Cardiovascular and Respiratory Mortality in People with Type 2 Diabetes and Chronic Obstructive Pulmonary Disease (COPD) in England: A Cohort Study Using the Clinical Practice Research Datalink (CPRD). Int J Chron Obstruct Pulmon Dis, 18, 1207-1218. http://doi.org/10.2147/copd.s407085
Chen, S., Miravitlles, M., Rhee, C. K., Pavord, I. D., Jones, R., Carter, V., et al. (2022). Patients with Chronic Obstructive Pulmonary Disease and Evidence of Eosinophilic Inflammation Experience Exacerbations Despite Receiving Maximal Inhaled Maintenance Therapy. Int J Chron Obstruct Pulmon Dis, 17, 2187-2200. http://doi.org/10.2147/copd.s378649
Rothnie, K. J., Joksaite, S., Sansbury, L. B., Compton, C., Di Boscio, V., & Ismaila, A. S. (2022). Characteristics of New Users of Single- and Multiple-Inhaler Triple Therapy for COPD in Primary Care in England. Int J Chron Obstruct Pulmon Dis, 17, 1455-1466. http://doi.org/10.2147/copd.s338436
Sansbury, L. B., Lipson, D. A., Bains, C., Anley, G. A., Rothnie, K. J., & Ismaila, A. S. (2022). Disease Burden and Healthcare Utilization Among Patients with Chronic Obstructive Pulmonary Disease (COPD) in England. Int J Chron Obstruct Pulmon Dis, 17, 415-426. http://doi.org/10.2147/copd.s336158
Amegadzie, J. E., Gamble, J. M., Farrell, J., & Gao, Z. (2022). Association between Inhaled β(2)-agonists Initiation and Risk of Major Adverse Cardiovascular Events: A Population-based Nested Case-Control Study. Int J Chron Obstruct Pulmon Dis, 17, 1205-1217. http://doi.org/10.2147/copd.s358927